Spelling suggestions: "subject:"optineurin"" "subject:"optineurine""
1 |
Role of Vesicular Glutamate Transporter 3 and Optineurin In Metabotropic Glutamate Receptor 5 SignalingIbrahim, Karim 06 February 2023 (has links)
Metabotropic glutamate receptor 5 (mGluR5) is a key regulator of numerous brain functions including memory, cognition, and motor behavior. Dysregulation of mGluR5 signaling is evident in Huntington's disease (HD) neuropathology, an inherited, neurodegenerative disease characterized with progressive deterioration in motor, cognitive, and psychiatric functions. In this context, two cellular proteins draw particular interest for this thesis: vesicular glutamate transporter 3 (VGLUT3) and optineurin (OPTN). VGLUT3 modulates glutamate release from selected neurons that are affected by HD, while OPTN is a mGluR5-interacting protein and contributes to neuronal vulnerability in HD. However, current evidence on their involvement in mGluR5 signaling and HD pathogenesis is still lacking. Using VGLUT3 knockout (VGLUT3⁻ᐟ⁻) mice, we showed that this transporter dynamically regulated glutamate receptor densities in different brain regions. Of note, VGLUT3 deletion upregulated mGluR5 in the cerebral cortex and the striatum, unlike the hippocampus which exhibited reduced mGluR5 cell surface densities. We then crossed VGLUT3⁻ᐟ⁻ mice with the zQ175 knock-in mouse model of HD (zQ175:VGLUT3⁻ᐟ⁻) to assess the impact of VGLUT3 transmission loss on HD progression. The longitudinal behavioral assessment revealed that VGLUT3 ablation rescued the deficits in motor coordination and short-term memory in both male and female zQ175 mice throughout 15 months of age. Furthermore, VGLUT3 deletion rescued striatal cell loss likely via activation of Akt and ERK1/2 cellular pathways, with no impact on total mutant huntingtin aggregation or the associated microgliosis. To delineate the role of OPTN in mGluR5 signaling, we employed a CRISPR/Cas9 OPTN-deficient cell line and global OPTN knockout mice. We demonstrated that OPTN was essential for mGluR5-mediated canonical signaling and ERK1/2 activation in both the striatal cell line, STHdh^Q7/Q7, and acute hippocampal slices. We then showed that OPTN deletion impaired autophagic machinery via GSK3β/ZBTB16 and mTOR/ULK1 signaling pathways downstream of mGluR5. This work offers novel insights into the molecular roles of VGLUT3 transmission and OPTN in mGluR5 signaling and provides a rationale for their targeting to therapeutically mitigate pathological mGluR5 signaling in HD.
|
2 |
Elucidating Cellular Mechanisms Underlying Retinal Ganglion Cell Neurodegeneration in a Human Pluripotent Stem Cell-Derived ModelHuang, Kang-Chieh 12 1900 (has links)
Indiana University-Purdue University Indianapolis (IUPUI) / Glaucoma is a leading cause of blindness characterized by the progressive loss of retinal ganglion cells (RGCs), essentially severing the connection between the eye and the brain. Among many underlying causes of the disease, mutations in the Optineurin (OPTN) gene result in severe RGC neurodegeneration in the absence of elevated intraocular pressure, providing a novel opportunity to study molecular mechanisms that lead to RGC neurodegeneration associated with glaucoma. Efforts of this study establishing a human pluripotent stem cell (hPSC)-derived in vitro disease model by inserting OPTN(E50K) mutation via CRISPR/Cas9 genome editing and investigate the cellular mechanisms of RGC neurodegeneration associated with glaucoma. OPTN(E50K) RGCs revealed neurodegeneration phenotypes, including downregulation of RGCs transcription factors, neurite retraction, and hyperexcitability, suggesting that OPTN(E50K) RGCs can serve as an appropriate disease model to study glaucoma-associated neurodegeneration. Since OPTN serves a primary role as an autophagy receptor, we further hypothesized that the OPTN(E50K) mutation disrupts autophagy in RGCs, and modulation of autophagy by mammalian target of rapamycin (mTOR)-independent pathways can preserve RGC phenotypes by maintaining mTOR signaling. OPTN(E50K) RGCs exhibited a higher number of OPTN puncta along with an overall reduced expression of OPTN protein, indicating a gain of toxic protein accumulation or loss of protein function. Furthermore, OPTN(E50K) RGCs revealed an accumulation of the autophagosome protein LC3 in a punctal manner as well as increased expression of lysosomal proteins, suggesting a disruption of degradation pathway in autophagosome and lysosome fusion. As mTOR complex 1 (mTORC1) signaling serves as a negative regulator of autophagy, a downregulation of mTORC1 signaling via activation of stress sensor adenosine monophosphate-activated protein kinase (AMPK) was observed as a possible compensatory mechanism for autophagy deficits in OPTN(E50K) RGCs. Pharmacological inhibition of mTOR in wild-type hRGCs resulted in similar disease-related phenotypes, while preservation of the mTOR pathway in OPTN(E50K) RGCs by treatment with the mTOR-independent autophagy modulator trehalose cleared OPTN accumulated puncta, preserving mTORC1 signaling, as well as rescuing neurodegenerative phenotypes. To further validate these associations in an animal model, the microbead occlusion mouse model was established by injection of magnetic microbeads in the anterior chamber to block aqueous outflow resulting ocular hypertension. In agreement with our findings in hRGCs, a decrease in mTOR signaling associated with an increase in the expression of autophagy-associated proteins was observed in RGCs in the microbead occlusion model. Additionally, these disease-related phenotypes were observed specifically within RGCs but not cortical neurons with an underlying OPTN(E50K) mutation, demonstrating that autophagy represents an essential pathway in RGCs to maintain homeostasis, and selective disrupt of autophagy in RGCs leads to neurodegeneration. Taken together, the results of this study highlight an essential balance between autophagy and mTORC1 signaling that is essential for the homeostasis of RGCs, while disruption to these signaling pathways contributes to neurodegenerative features in glaucoma. These results also demonstrated the ability to pharmacologically intervene to experimentally manipulate these pathways and rescue neurodegenerative phenotypes, providing a potential therapeutic target to prevent glaucoma-associated neurodegeneration.
|
3 |
Investigating the role of optineurin in bone biology and Paget's disease of boneObaid, Rami Abdulhadi Abdulmajeed January 2016 (has links)
Paget’s disease of bone (PDB) is a common disease with a strong genetic component. Approaches such as linkage analysis and candidate gene studies have shown that mutations in Sequestosome 1 (SQSTM1) explain up to 40% of familial cases and 10% of sporadic cases, however the majority of PDB patients have no mutations in this gene. Genome-wide association studies (GWAS) have recently identified new susceptibility loci for PDB including variants at CSF1, TNFRSF11A, OPTN, TM7SF4, PML, NUP205 and RIN3 loci. These loci were confirmed to be associated with PDB in various European populations. OPTN encodes optineurin, a widely expressed protein involved in many cellular processes but its role in bone metabolism is yet unknown. The aim of this PhD thesis was to investigate the role of OPTN in bone metabolism and PDB using in vitro and in vivo studies. In chapter 3, the OPTN rs1561570 identified by previous GWAS was examined for its association with the severity and clinical outcome of PDB in patients without SQSTM1 mutations. The results showed that rs1561570 was significantly associated with total disease severity score so that carriers of the risk allele “T” had higher severity score compared to non-carriers (P < 0.05). A trend for reduced quality of life physical scores (SF36) was also associated with the rs1561570 risk allele, but the relationship was not statistically significant. In order to identify functional variants within OPTN, the coding regions as well as the exon-intron boundaries were sequenced in 24 familial PDB cases and 19 controls. No mutation was found that could be predicted as pathogenic suggesting that disease susceptibility could be mediated by regulatory polymorphisms that influence gene expression. In chapter 4, the role of OPTN was investigated in osteoclast development using in vitro knockdown experiments. Optn was expressed in mouse bone marrow derived macrophages (BMDMs) as well as all stages of osteoclast development and it was significantly increased three days post RANKL treatment. Optn expression was knocked down in BMDMs and cells were induced to form osteoclast in the presence of RANKL and M-CSF. Compared to non-targeted cells, Optn depleted cells formed significantly more and larger osteoclasts (P< 0.05). Optn knockdown was also found to enhance osteoclast survival as well as RANKL-induced NFκB activation. In chapter 5, the role of OPTN was investigated in vitro from cells obtained from knock in mice with a loss-of-function mutation in Optn (OptnD477N/D477N). In agreement with the in vitro knockdown experiments, osteoclasts were significantly higher and larger in mutant mice compared to WT and the NF-B activity measured by luciferase reporter assay was significantly higher in cells from OptnD477N/D477N compared to WT during most stages of osteoclast development. OPTN from mutant and WT mice was co-precipitated with its CYLD binding-partner, which acts as a negative regulator to RANK signalling by inhibiting the TRAF6 downstream signalling. The data from this immunoprecipitation (IP) experiment revealed that defective OPTN interacted less with CYLD from mutant mice compared to WT. This study also showed that OPTN was expressed in osteoblasts and the expression rate did not change during osteoblast development. The data obtained from the mineralization assay revealed no significant difference between OptnD477N/D477N and WT. In chapter 6, I investigated the effect of the D477N loss of function mutation in Optn on bone metabolism. Bone Histomorphometrical analysis of OptnD477N/D477N mice showed higher bone resorption parameters (Oc.N/BS and Oc.S/BS) compared to wild type (WT). Osteoid analysis showed evidence of increased bone formation parameters (OS/BS and OV/BV) in mutant mice compared to WT. Calcein labelling showed a significant difference in mineral apposition rate (MAR) from mutant mice compared to WT. Analysis of serum biomarkers of bone turnover showed evidence of enhanced bone turnover in mutant mice compared to WT. Micro computed tomography (μCT) analysis of 4 and 14 months old mice showed no significant differences in bone morphology between WT and OptnD477N/D477N mice of both sexes. In conclusion, this study has shown for the first time that OPTN plays a role in regulating bone turnover by acting as a negative regulator of osteoclast differentiation. The data obtained from this study strongly suggest the crucial role of OPTN in RANK signalling. The effect of OPTN on osteoblast activity may be direct or indirect compensation for increased osteoclast activity. Further detailed studies will be required to explore the underlying mechanism of OPTN including downstream RANK signalling and a complete knockout model to corroborate these findings.
|
4 |
Phosphorylated NF-κB subunit p65 aggregates in granulovacuolar degeneration and neurites in neurodegenerative diseases with tauopathy / タウオパチーを伴う神経変性疾患における顆粒空胞変性および神経突起におけるリン酸化NF-κBサブユニットp65の凝集体Yamaguchi, Yuko 23 March 2020 (has links)
京都大学 / 0048 / 新制・課程博士 / 博士(医学) / 甲第22357号 / 医博第4598号 / 新制||医||1042(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 井上 治久, 教授 伊佐 正, 教授 渡邊 直樹 / 学位規則第4条第1項該当 / Doctor of Medical Science / Kyoto University / DFAM
|
5 |
Mécanisme de la dérégulation du cycle cellulaire de l'hôte par Staphylococcus aureus / Méchanisms of regulation of the host cell cycle by Staphylococcus aureusEl Aour Filho, Rachid Aref 03 November 2016 (has links)
Staphylococcus aureus est une bactérie Gram positive qui colonise la peau des animaux et des humains sains. Dans certaines conditions, telles que la perturbation du microbiote, S. aureus peut induire différentes maladies en déjouant les fonctions de défenses de la cellule hôte. Récemment, notre équipe a montré que les S. aureus méthiciline-résistant (MRSA) souche MW2 (USA400) étaient capables d’induire un retard de la transition de phase G2/M des cellules HeLa. Dans ce travail, nous avons démontré que cette action est initiée par des composants du surnagent de culture de S. aureus.Différentes fractions de surnagents de culture de MW2 ont été obtenues par la chromatographie d’exclusion et analysées par la spectrométrie de masse. Ces techniques nous ont permis d’identifier les peptides phenol-soluble modulins alpha (PSMa) comme responsables du retard du cycle cellulaire des cellules hôtes. Confirmant l’implication de ces modulines, la souche LAC¿psma déficiente en PSMa 1 – 4, n’a pas affecté la progression normale du cyle cellulaire de cellules epitheliales HeLa. De plus, le traitement de ces cellules avec des PSMa1 et PSMa3 synthétiques a induit un retard de la transition de phase G2/M qui a été associé à la diminution de l’expression de gènes codant des défensines ß. Enfin, nous avons démontré que la souche MW2 diminue le niveau d’optineurine et d’optineurine phosphorylée sur la sérine-177, une protéine hôte qui est impliquée dans la transition de phase G2/M. Ce travail représente une étape importante de la compréhension du mécanisme d’interférence de S. aureus / Staphylococcus aureus is a Gram-positive bacterium that colonizes the skin of healthy animals and humans. In certain conditions, including the disruption of the commensal microbiota, S aureus can cause different diseases by deviating the host defense functions. Recently, our group has shown that the methicillin-resistant S. aureus (MRSA) MW2 (USA400) strain causes delay in the transition of the G2/M phase of HeLa cells. In the present work, we demonstrated that this action is initiated by components of the supernatant of the S. aureus culture. Different supernatant fractions were obtained by size exclusion chromatography and were analyzed by mass spectrometry, which allowed to identify phenol-soluble modulins alpha (PSMa) as responsible for the host cell cycle delay.Confirming the involvement of these modulins in the delay, the MRSA LAC¿psma strain, which is deficient in PSMa1–4, did not affect the normal progression of the cycle in HeLa cells. In addition, the treatment of these cells with synthetic PSMa1 and PSMa3 caused delay in the transition of the G2/M phase associated with the decreased production of host ß-defensins. Lastly, we demonstrated that the MW2 strain, which produce PSMa, decreases the level of optineurin and optineurin phosphorylated at serine 177, a host protein that is involved in the G2/M phase transition. The work conducted in this thesis represents an important achievement in the understanding of how S. aureus interferes with the host cell cycle, revealing a new role for PSMa produced by this bacterium.
|
6 |
Characterization of the Effect of Optineurin on Alpha-synuclein Aggregation andToxicity in YeastIslam, Md Moydul 30 August 2018 (has links)
No description available.
|
7 |
Implication de l’appareil de Golgi et de l’ubiquitination dans l’activation de TBK1 après détection des ARNs viraux / Involvement of Golgi apparatus and ubiquitination in TBK1 activation after viral RNAs detectionPourcelot, Marie 21 September 2016 (has links)
L’immunité innée antivirale repose en grande partie sur la production des interférons de type I (IFN-α/β) par les cellules infectées et les cellules immunitaires. Cette synthèse résulte de la reconnaissance de motifs viraux caractéristiques par des récepteurs cellulaires, parmi lesquels les RIG-I-Like Récepteurs (RLR) et le Toll-Like Récepteur 3 (TLR3) détectent l’ARN viral respectivement au niveau du cytosol et des endosomes. La signalisation induite par les RLRs et TLR3 conduit à l’activation d’IRF3 et de NF-κB, deux facteurs de transcription impliqués respectivement dans la production d’IFN-α/β et de cytokines pro-inflammatoires. TBK1 (TANK-Binding Kinase 1) joue un rôle essentiel dans l’immunité innée antivirale, de par la phosphorylation du facteur de transcription IRF3, nécessaire à la production des IFNs de type I. Bien que de nombreuses études aient montré le rôle crucial de cette kinase dans la signalisation antivirale, le processus entrainant son activation est encore mal déterminé à ce jour. Lors de cette étude nous avons démontré que suite à la stimulation du TLR3 et des RLRs, la forme active, ubiquitinylée et phosphorylée, de TBK1 se relocalise au niveau de l’appareil de golgi, grâce à son ubiquitination sur les résidus K30 et K401. Ce mécanisme implique la reconnaissance des chaines d’ubiquitines associées à TBK1 par l’Optineurine (OPTN), permettant la formation d’un complexe autorisant le rapprochement des molécules de TBK1 puis la trans-autophosphorylation au niveau de l’appareil de Golgi. Au cours de ce travail nous avons également découvert qu’OPTN est la cible d’une protéine virale, la protéine NS3 du BTV (Bluetongue Virus), qui neutralise son activité et diminue ainsi l’activation de TBK1 et la signalisation responsable de la sécrétion de cytokines antivirales. / Type-I interferons (IFN-α/β) production and release is a major event in innate antiviral immunity. IFN production depends on the interaction between viral structures and their corresponding cellular sensors. RIG-I-Like Receptors (RLRs) and Toll-Like Receptor 3 (TLR3) sense dsRNAs in the cytosol and endosomes respectively. Stimulation of these receptors by their ligands promotes a signal transduction leading to the activation of the transcription factors NF-κB and IRF3, and consequently to the production of proinflammatory cytokines and Type I Interferons (IFN-I). TBK1 (TANK-Binding Kinase 1), plays a crucial role in antiviral innate immunity, by phosphorylating the transcription factor IRF3, required for the production of type I IFNs. Although many studies have shown the critical role of this kinase in antiviral signaling, the molecular mechanism of its activation are largely unknown. We report here the localization of the ubiquitinated and phosphorylated active form of TBK1 to the Golgi apparatus after the stimulation of RLRs or TLR3, due to TBK1 ubiquitination on lysine residues 30 and 401. The ubiquitin-binding protein optineurin (OPTN) recruits ubiquitinated TBK1 to the Golgi apparatus, leading to the formation of complexes in which TBK1 is activated by trans-autophosphorylation. We also found that a viral protein binds OPTN at the Golgi apparatus, neutralizing its activity and thereby decreasing TBK1 activation and downstream signaling.
|
Page generated in 0.2352 seconds